Timolol eye drops 0.5%: Clinical Trials

1 trial of Timolol eye drops 0.5%, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Timolol eye drops 0.5%: new trials by email Literature Review of Timolol eye drops 0.5% trials Research Report on Timolol eye drops 0.5%

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery
TimoD implant, Injector system, Timolol eye drops 0.5% - Glaucoma, Ocular Hypertension
Phase 1 / Phase 2RecruitingEyeD Pharma422025-06-122026-07-30

Conditions studied

Cataract (1)  ·  Glaucoma (1)  ·  Lens Diseases (1)  ·  Ocular Hypertension (1)

Sponsors

EyeD Pharma (1)

Countries

Panama (1)